BRAINSTORM CELL THERAPEUTICS INC. (BCLI) IPO — S-1 Filing, Stock & Insider Activity

BRAINSTORM CELL THERAPEUTICS INC. IPO — Status & S-1 Filing

Ticker: BCLI
Status: Registered — S-1 filed with the SEC
S-1 filed: 2026-05-21
Exchange: NASDAQ
Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
Shares offered: 1,310,528
SEC CIK: 0001137883 · View the S-1 on SEC EDGAR →

Track every registration update on the InsiderAlpha IPO tracker.

Updated Jul 16, 2026 · Last SEC filing 2026-05-29

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-29. 2 Form 8-K material event filings were reported by BCLI in the last 90 days. InsiderAlpha tracks every BCLI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

SEC CIK	0001137883

90-Day SEC Filing Activity

Form 4 filings (90d)	11
Form 8-K filings (90d)	2
Latest Form 4 filing	2026-05-29

Recent BCLI Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-02-26	Yablonka Uri	EVP & Chief Business Officer	A — Grant or award	150.0K	$0.00	—	SEC
2026-02-26	FRENKEL JACOB A	Director	A — Grant or award	200.0K	$0.00	—	SEC
2026-02-26	ARBEL IRIT	Director	A — Grant or award	120.0K	$0.00	—	SEC
2026-02-26	Lebovits Chaim	President & CEO	A — Grant or award	1.80M	$0.00	—	SEC
2026-02-26	Patlis Alla	See Remarks	A — Grant or award	100.0K	$0.00	—	SEC
2024-10-01	Lebovits Chaim	President & CEO	P — Open-market purchase	1.8K	$3.43	$6K	SEC
2024-09-30	Lebovits Chaim	President & CEO	P — Open-market purchase	22.0K	$0.23	$5K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for BRAINSTORM CELL THERAPEUTICS INC. (BCLI). Updated in real time as new filings are submitted to the SEC.

Most-Active BCLI Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Lebovits Chaim	1	—
Bairu Menghisteab	1	$105K
Polverino Anthony J.	1	$105K
HARTOUNIAN HARTOUN	1	$158K
Lindborg Stacy	1	$105K

Recent BCLI Form 8-K Material Events

2026-05-28 — Item 5.02, 7.01, 9.01 [SEC]
2026-05-15 — Item 2.02, 9.01 [SEC]
2026-03-31 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Brainstorm Cell Therapeutics issued a press release on March 31, 2026 announcing its financial results for the year ended December 31, 2025. The filing provides standard annual financial results without explicit beat/miss or guidance language.
2026-02-27 — Item 1.01, 3.02, 5.02, 9.01 · Financing · neutral [SEC]
Brainstorm Cell Therapeutics entered into a Securities Purchase Agreement for a private placement of up to $1,000,000 in common stock and pre-funded warrants with an accredited investor. The first closing of $125,000 occurred on February 24, 2026, with up to seven additional clos

Recent Insider Filings

2026-05-29 — Lebovits Chaim (President & CEO)
2026-05-29 — Yablonka Uri (EVP & Chief Business Officer)
2026-05-29 — Patlis Alla (See Remarks)
2026-05-29 — FRENKEL JACOB A (Director)
2026-05-29 — ARBEL IRIT (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BCLI insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

BCLI Insider Trading — FAQ

What is the latest insider trade for BCLI?: BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had 11 insider filings in the last 90 days, with the most recent on 2026-05-29. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying BCLI stock?: 0 insider purchases of BCLI were filed in the last 90 days.
How many insiders are selling BCLI stock?: 0 insider sales of BCLI were filed in the last 90 days.
Where can I see BCLI SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every BCLI SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live BCLI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.